About
Thaysen holds an M.Sc. and a Ph.D. in physics from the Technical University of Denmark, according to Illumina's proxy statement. He founded Cantion in 2001 and later held a research and development role at Dako, a Danish cancer diagnostics company that Agilent acquired in 2012. At Agilent he led the Diagnostics and Genomics Group and then the Life Sciences and Applied Markets Group. Other life sciences and healthcare leaders with pages on Whoo include Marc Casper of Thermo Fisher Scientific and Geoff Martha of Medtronic.
Whoo compiled this page from public sources: Illumina third-quarter 2026 results release, Illumina 2026 proxy statement (SEC), GEN. It is not affiliated with or endorsed by Jacob Thaysen. Are you Jacob Thaysen? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.
Want a page like this? Create yours from your résumé.
Experience
Chief Executive Officer — Illumina
2023 – Present | San Diego, California
- Board member since 2023
- Chair of ALDA (Analytical, Life Science & Diagnostics Association) since 2023
- Dako is a Danish cancer diagnostics company that Agilent acquired in 2012
Senior Vice President and President, Life Sciences & Applied Markets Group — Agilent Technologies
2018 – 2023
Senior Vice President and President, Diagnostics & Genomics Group — Agilent Technologies
2014 – 2018
Vice President and General Manager, Diagnostics & Genomics — Agilent Technologies
2013 – 2014
Corporate Vice President, R&D — Dako
2010 – 2013
Founder and Chief Technology Officer — Cantion
2001